Literature DB >> 12140668

Longitudinal MRI study of multiple system atrophy - when do the findings appear, and what is the course?

Yoshihiko Horimoto1, Ikuko Aiba, Takeshi Yasuda, Yoshinori Ohkawa, Taiji Katayama, Yuki Yokokawa, Atsuko Goto, Yasuhiro Ito.   

Abstract

Several investigators have revealed features of multiple system atrophy (MSA) by magnetic resonance imaging (MRI). For use in clinical diagnosis, we determined the exact time when two main features of pontine and putaminal intensity changes appeared. Furthermore, in order to reveal the course from when the disorder first appeared and how it spread, we also investigated the course of MRI findings and differences between clinical subtypes. The cranial MRI of 42 patients with MSA were longitudinally studied including comments on the so called "cross sign" of pontine T2 high intensity, which was divided into 6 stages, and also on the linear T2 high intensity of the dorsolateral side of the putamen ("putaminal slit") which was divided into 4 stages. Patients were classified as 16 MSA-C, 7 autonomic dominant type (MSA-A), and 19 MSA-P. The age at onset ranged from 41 to 74 years (mean, 55 +/- 9). The duration of the disease in the MRI study ranged from 1 to 24 years. The pontine "cross sign" was completed (shows Cross, stage IV) earlier in MSA-C mainly before 5 years, later in MSA-P and even much later in MSA-A. Regarding the "putaminal slit", MSA-P shows earlier bilateral changes (stage II), mostly before 3 years, compared with MSA-C, which requires 4 years to reveal even a unilateral change (stage I), or MSA-A which requires even more time. MRI findings showed a tendency to relate to clinical findings, since MSA-C exhibits "cross sign" completion earlier than bilateral "putaminal slit"; however, MSA-P shows bilateral "putaminal slit" earlier than "cross sign", and MSA-A requires much more time to show both. Clinically, MSA-C, MSA-A, or MSA-P showed different MRI courses so that three subtypes could be defined also with MRI findings. Therefore these observations are useful not only for diagnosis of MSA itself, but also to distinguish clinical subtypes (MSA-C, MSA-A, or MSA-P) which have different rates of lesion progression.

Entities:  

Mesh:

Year:  2002        PMID: 12140668     DOI: 10.1007/s00415-002-0734-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  31 in total

1.  Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging.

Authors:  Masato Kanazawa; Takayoshi Shimohata; Kenshi Terajima; Osamu Onodera; Keiko Tanaka; Shoji Tsuji; Kouichirou Okamoto; Masatoyo Nishizawa
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

2.  Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging.

Authors:  Kazumichi Tsukamoto; Eiji Matsusue; Yoshiko Kanasaki; Suguru Kakite; Shinya Fujii; Toshio Kaminou; Toshihide Ogawa
Journal:  Neuroradiology       Date:  2012-01-25       Impact factor: 2.804

Review 3.  How to diagnose MSA early: the role of magnetic resonance imaging.

Authors:  K Seppi; M F H Schocke; G K Wenning; W Poewe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

Review 4.  Neuroimaging of rapidly progressive dementias, part 1: neurodegenerative etiologies.

Authors:  A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-22       Impact factor: 3.825

5.  Significance of the hot-cross bun sign on T2*-weighted MRI for the diagnosis of multiple system atrophy.

Authors:  Kazushi Deguchi; Kazuyo Ikeda; Kodai Kume; Tadayuki Takata; Yohei Kokudo; Masaki Kamada; Tetsuo Touge; Naomi Honjo; Tsutomu Masaki
Journal:  J Neurol       Date:  2015-04-07       Impact factor: 4.849

Review 6.  Diagnosis and differential diagnosis of MSA: boundary issues.

Authors:  Han-Joon Kim; Beom S Jeon; Kurt A Jellinger
Journal:  J Neurol       Date:  2015-02-07       Impact factor: 4.849

7.  Callosal tissue loss in multiple system atrophy--a one-year follow-up study.

Authors:  Martina Minnerop; Eileen Lüders; Karsten Specht; Jürgen Ruhlmann; Nicole Schimke; Paul M Thompson; Yi Y Chou; Arthur W Toga; Michael Abele; Ullrich Wüllner; Thomas Klockgether
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

Review 8.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

Review 9.  Diagnosis of multiple system atrophy.

Authors:  Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  Auton Neurosci       Date:  2017-10-23       Impact factor: 3.145

10.  Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants.

Authors:  Kenichi Oishi; Andreia Faria; Hangyi Jiang; Xin Li; Kazi Akhter; Jiangyang Zhang; John T Hsu; Michael I Miller; Peter C M van Zijl; Marilyn Albert; Constantine G Lyketsos; Roger Woods; Arthur W Toga; G Bruce Pike; Pedro Rosa-Neto; Alan Evans; John Mazziotta; Susumu Mori
Journal:  Neuroimage       Date:  2009-06       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.